Whitepaper

Current Treatment Challenges Of IO Refractory Patients And Clinical Development Of Therapies Targeting These Patients
Harnessing the power of own immune cells, Immuno-oncology therapies are carving out a nice in oncology treatment landscape
CURRENT TREATMENT CHALLENGES OF IO REFRACTORY PATIENTS AND CLINICAL DEVELOPMENT OF THERAPIES TARGETING THESE PATIENTS

More Whitepapers / Newsletters

Cancer In The United States(Vol 1, Issue 2)
Cancer In The United States(Vo...

US Cancer Statistics show that more than half a million suffer from this disease, which is the second leading cause of death in the country. The newsletter Cancer in the US substantiates the increasin...

Fibrodysplasia Ossificans Progressiva Newsletter
Fibrodysplasia Ossificans Prog...

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification of the connective tissues and muscle tissues, such as ligaments and tendons. They are replaced by bo...

Age-Related Macular Degeneration Market
Age-Related Macular Degenerati...

Age-related macular degeneration (AMD) is an eye disease, which may obscure the simple, central use of vision for activities such as reading and driving. It can be of two types−dry macular degeneratio...

The Sanitization Revolution: A Global Powerhouse
The Sanitization Revolution: A...

Sanitization is a key factor in rural and urban India. The lack of adequate sanitization is a very pressing challenge in India. The sanitization related diseases take a heavy toll of lives especially...

Schizophrenia Market
Schizophrenia

Schizophrenia is a severe mental illness that interferes with a person's ability to think clearly, manage emotions, make decisions, and relate to others. It is a complex, long-term medical illness, af...